Leveraging Friends Against Foes: Use of Microbial Communities to Prevent Infection and Transmission
Learning Objectives
- Examine new avenues with which infectious diseases and their transmission can be controlled.
- Review how advances in microbial ecology can support both therapeutics and infection control.
- Discuss the advantages and challenges of incorporating microbial communities into patient care.
- Preventing infections and transmission trough microbial communities
- Microbiome protectants, restoratives and therapeutics for treatment of infections - current evidence and future perspectives
- Fecal microbiota transplantation for prevention of transmission of multidrug-resistant organisms
- Q&A
Speakers
Alison Laufer Halpin, PhD, MPhil
Centers for Disease Control and Prevention
No relationships to disclose
Eric Pamer, MD
University of Chicago
No relationships to disclose
Stephan Harbarth, MD, MS
Geneva University Hospitals
No relationships to disclose
Coordinator
Sarah Tschudin-Sutter, MD, MSc
University of Basel
Consulting fee: Shionogi B.V. Amsterdam
Alison Laufer Halpin, PhD, MPhil
Centers for Disease Control and Prevention
No relationships to disclose
Available Credit
- 1.50 ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point’s equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 1.50 AMA PRA Category 1 Credit™The Society for Healthcare Epidemiology of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.50 Participation